Is Meropenem as a Monotherapy Truly Incompetent for Meropenem-Nonsusceptible Bacterial Strains? A Pharmacokinetic/Pharmacodynamic Modeling With Monte Carlo Simulation
Author:
Publisher
Frontiers Media SA
Subject
Microbiology (medical),Microbiology
Reference72 articles.
1. Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria;Avery;Expert Opin. Investig. Drugs,2018
2. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States;Bartsch;Clin. Microbiol. Infect.,2017
3. Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy;Bergogne-Bérézin;Eur. J. Clin. Pharmacol.,1994
4. Carbapenem-nonsusceptible Acinetobacter baumannii, 8 US metropolitan areas, 2012-2015;Bulens;Emerg. Infect. Dis.,2018
5. The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis;Burgess;Clin. Microbiol. Infect.,2007
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients;2024-01-18
2. Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa;Frontiers in Cellular and Infection Microbiology;2023-06-28
3. Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases;Frontiers in Cellular and Infection Microbiology;2023-06-21
4. Evaluation of the Efficacy of Optimized Two-Step-Administration Therapy with Ceftazidime/Avibactam for Treating Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> Pulmonary Infections: a Pharmacokinetic/Pharmacodynamic Analysis;Japanese Journal of Infectious Diseases;2023-01-31
5. Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis;Antibiotics;2022-09-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3